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Incidence of Diagnosed Deep Vein Thrombosis in the
General Population: Systematic Review
F. J. I. Fowkes, J. F. Price and F. G. R. Fowkes
Wolfson Unit for Prevention of Peripheral Vascular Diseases, Public Health Sciences, University of Edinburgh,
Teviot Place, Edinburgh EH8 9AG, Scotland
Objective: to determine the incidence of deep vein thrombosis (DVT) in the general population by pooling results from all
studies of adequate quality.
Design: systematic review including meta-analysis.
Material and Methods: MEDLINE (1966±2001) and EMBASE (1950±2001) were searched for studies on the incidence
of DVTand thromboembolism in the general population. Studies had to attain minimum inclusion and quality criteria to be
accepted for the review, including adequate specification of the diagnosis of DVT and the age range of the population. The
appraisal of studies for inclusion and abstraction of data were carried out independently by each author. Incidence rates were
adjusted to standardise for differences between studies in categories of DVT and population age structures. Weighted and
unweighted means of incidence per 10 000 person years were estimated.
Results: nine studies were identified which fulfilled the inclusion and quality criteria. Most were conducted in Sweden or
U.S.A. between 1976 and 2000. The weighted mean incidence of first DVT in the whole general population was 5.04 (95%
CI 4.70, 5.38) per 10 000 person years. The incidence was similar in males and females and increased dramatically with age
from about 2±3 per 10 000 person years at age 30±49 to 20 per 10 000 person years at age 70±79. Around 40% of cases of
DVT were idiopathic.
Conclusion: this study provides the most comprehensive estimate to date of the incidence of DVT in the whole general
population ± around 5 per 10 000 per annum ± and is a useful background figure for comparison with incidence in high risk
groups.
Key Words: Incidence; Deep vein thrombosis; Population; Systematic review.
Introduction
Recent medical and public interest in the risks of deep
vein thrombosis (DVT) associated with long distance
air travel has highlighted the need for more accurate
data on the incidence in travellers.1 In the general
population, the incidence of traveller related venous
thromboembolism was estimated to be around 0.4 to
3 per 10 000 population per annum2 and the incidence
of DVT associated with flying to be about 1 to 2.5 per
10 000 travellers.3 These figures were however esti-
mated and greater precision is required.
In calculating the size of an increased risk among
travellers, the incidence among a non travelling com-
parable group is required. Knowledge of the back-
ground risk in the general population is also helpful
in putting travel associated risks in context. Reviews
of the epidemiology of venous thromboembolism
have emphasised the importance of general popula-
tion surveys in providing a true picture of the occur-
rence of disease in the community.4,5 But, since DVT
cannot be diagnosed solely by history and physical
examination alone and requires specialist investiga-
tion, incidence cannot be measured easily in such
population surveys. Most of the evidence on incidence
is available from the detection of cases diagnosed in
health care facilities serving a defined population. We
performed a systematic review of relevant studies in
order to provide a comprehensive estimate of the inci-
dence of DVT in the general population.
Material and Methods
MEDLINE (1966±2001) and EMBASE (1950±2001)
were searched for studies on the incidence of
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DVT and thromboembolism. The criterion for inclu-
sion of studies was the reporting of all diagnosed
patients with DVT in a defined general population in
a developed country. The reference lists of selected
papers were searched for further studies. The min-
imum quality criteria for inclusion in the review
were that: DVT diagnoses were confirmed by clinical
tests (phlebography, duplex scan) or a satisfactory
validation study confirming the accuracy of the diag-
noses had been performed; the age range of a defined
catchment population was specified; and incidence
rates could be estimated per 10 000 person years.
The studies which met the initial inclusion criteria
were assessed independently by each of the authors to
ascertain that each fulfilled the criteria and further-
more attained the minimum quality criteria for inclu-
sion in the review. The final list of included papers
was agreed by discussion. Each author then inde-
pendently abstracted data from each of the studies
and calculated crude incidence rates. The final rates
to be included were then agreed by discussion
between the authors. Also, all authors confirmed the
subsequent calculations by one author (FGRF) of
adjusted incidence rates as described below. Mean
incidence rates were calculated by one author (FJIF)
and checked by the others.
The studies were not consistent in their inclusion or
exclusion of DVTs which were recurrent, DVTs which
were combined with pulmonary embolism, and DVTs
due to all causes. The age ranges of the reference
populations also differed. These differences would
lead to inconsistencies in the crude incidence rates
between studies and would not permit meaningful
pooling of the incidence rates. We decided to define
incidence rates for the purpose of this meta-analysis
according to the most frequently reported, that is, only
new DVT cases which were not combined with pul-
monary embolism and were due to any cause. We
therefore had to make adjustments derived from the
published evidence6±11 to those incidence rates not
defined as above and to those based on restricted
age ranges. These adjustments were pre-specified
and were not changed following calculation of the
adjusted incidence rates. The adjustments comprised:
0.75 for studies including new and recurrent DVTs
because in such studies approximately 75% would
be new DVTs;6,7 0.8 for those including DVTs
with pulmonary embolism because in such studies
approximately 80% would have a DVT but no detect-
able pulmonary embolism;8,9 and 2.5 for those
including only `` idiopathic'' DVT because around
40% of all DVTs are `` idiopathic''.9,10 Age adjustments
were based on age specific distributions of incidence
detailed in two studies10,11 and incidence rates in
studies with a restricted age range recalculated for a
population of all ages.
In pooling the incidence rates from each study to
produce an overall rate, means of the incidence rates
were estimated unweighted and weighted by person
years of follow up in each study. In the unweighted
method, the means were simply added and divided
by the number of studies. In the weighted method,
each incidence rate was multiplied by the number of
person years of observation in the study; this result
was then summed for all the studies, and then divided
by the sum of the weights.5,12
Results
The search identified 19 possible studies according
to the title of the paper and information in the
abstract. On detailed examination of the 19 papers,
only 11 fulfilled the initial inclusion criteria.6±11,13±17
Two of these 11 studies did not meet the additional
quality criterion of adequate diagnostic confirm-
ation,16,17 and were excluded. The remaining nine stu-
dies6±11,13±15 were published between 1976 and 2000
and comprised analyses of DVTs which were identi-
fied: (a) in hospitals with defined populations,8,10,11,
13±15 (b) in national discharge data sets,7,9 or (c) in a
population cohort study.6 The characteristics of the
studies are shown in Table 1. Most were conducted in
Sweden or the U.S.A. The diagnosis of deep vein
thrombosis was made in most studies using phlebogra-
phy or in three studies7±9 a satisfactory validation
study of discharge diagnoses was performed. This
comprised detailed review of samples of medical
records confirming that in most cases the discharge
diagnosis was correct. In most studies, the population
denominator was derived from a census and com-
prised all age ranges, except for three studies in
which the age ranges were restricted.6,7,9
Table 2 shows that the adjusted incidence rates
derived from the nine studies encompassed a narrow
range with the incidence in seven studies clustering
around 5.0 per 10 000 person years and the remaining
two studies having incidences of 8.7 and 9.5 per 10 000
person years. The unweighted mean was 5.97 (95% CI
4.78, 7.16) and the weighted mean was 5.04 (95% CI
4.70, 5.38) per 10 000 person years. This weighted
mean was influenced substantially by two studies7,9
which were very much larger than the others.
DVT occurred rarely below 20 years of age but,
above 20 years, the incidence increased markedly
with age.6,8±11,13±15 The annual incidence rates by
age group were approximately: 2±3 per 10 000 (30±
49 years), 5 per 10 000 (50±59 years), 10 per 10 000
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(60±69 years) and 20 per 10 000 (70±79 years).6±9,14,15
The incidence was similar in males and females as
indicated by the male : female ratios (Table 2); there
was some suggestion of a higher rate in women than
in men during the reproductive years which was
reversed after the menopause10,11,13 but this was not
a consistent finding.8,14,15 The causes of DVT were
attributed mostly to cancer or previous hospitalisation
(around one quarter to one third of causes in each
case8±10), and around 40% were idiopathic.9,10
Discussion
This systematic review provides the best available
evidence of the incidence of newly diagnosed DVT
in the general population (but does not include indi-
viduals with asymptomatic DVT or those with symp-
toms who were not investigated). Newly diagnosed
DVT appears to occur in around 5 per 10 000 of the
whole population per annum (i.e. 1 per 2000) of whom
2 per 10 000 are idiopathic. An additional 1±2 per
10 000 have a new DVT combined with pulmonary
embolism. The incidence of DVT is very strongly age
related and in the population as a whole is compar-
able in men and women.
The increased risks of DVT within subgroups of the
general population may be substantial. For example,
in a population based study in the U.S.A.,4 institution-
alisation was associated with an 8 fold increase in risk
of DVT or pulmonary embolism, and this rose to
22 fold if accompanied by surgery. Trauma was asso-
ciated with a 13-fold increase and malignancy with a
5-fold increase in risk. The relative risks of throm-
boembolism among women using oral contraceptives
or hormone replacement therapy is around 2±4 com-
pared to non-users.18,19 Inherited or acquired throm-
bophilia, such as those associated with activated
protein C resistance and Factor V Leiden mutation,
may increase risk very substantially such that it
has been suggested that `` an acquired or familial
thrombophilia may underlie all episodes of venous
thromboembolism''.4
In estimating the typical background incidence in a
group of individuals exposed to a potentially high risk
situation, such as prolonged air travel, consideration
must be given to the age distribution of the group and
the presence of other risk factors such as thrombophi-
lia, malignancy and recent hospitalisation. The same
diagnostic category of DVT and an appropriate com-
parison population must be used. These methodo-
logical requirements are not always followed. For
example, in a recent report of the risk of thromboem-
bolism in airline pilots,20 the diagnostic category was
not defined and the incidence in the pilots was com-
pared with that in only one small population study in
Sweden.6 While this present systematic review pro-
vides useful summary data which can be used for
approximate comparison purposes, the increased
risks in long distance air travellers can only be esti-
mated with precision by means of studies using prop-
erly matched control groups.
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